… Hence the working hypothesis underlying the use of dendritic cells in tumor vaccination
is … from the tumor cell to the dendritic cell, and that direct loading of dendritic cells with the …

… Although currentdendritic cell–based vaccination methods … cancer suggest that
immunotherapeutic strategies that take advantageof the antigen presenting properties of dendritic …

… in cancer tissue and draining lymph nodes usually carry an “immature” phenotype and that
myeloid-derived suppressor cells (… I will then discuss how DC-based immunotherapy can be …

… Cancer cells attract immature dendritic cells (DCs), possibly through chemokines such as
CCL20 or CXCL12. DCs can then be exposed to cancer-derived factors — for example, thymic …

… Although dendritic cells (DCs) constitute a rare immune cell population within tumours and
lymphoid organs, these cells are central for the initiation of antigen-specific immunity and …

… cancer stem cells [3]. So, the question is now by which means we can improve immunotherapy
for cancer … Different immunotherapeutic strategies more or less directly target a leukocyte …

… Dendritic cells (DC) play an essential role in the induction and regulation of immune
responses, … Cancer immunotherapy via dendritic cells Nat Rev Cancer, 12 (2012), pp. 265-277 …

DC initiate and regulate T‐cell immunity and are thus the key to optimization of all types of
vaccines. Insights into DC biology offer many opportunities to enhance immunogenicity. In this …

… A novel approach to vaccination against cancer is to exploit dendritic cells (DCs) as ‘nature’s
adjuvants’ and actively immunize cancer patients with a sample of their own DCs primed …

… Use of these cells in cancer immunotherapy has been bolstered by newer insights in DC …
Active immunization against cancer with dendritic cells: the near future. Int J Cancer. 2001;…